Literature DB >> 29856564

Is there compelling evidence that schizophrenia long-term treatment guidelines should be changed?

Stefan Leucht1.   

Abstract

Entities:  

Year:  2018        PMID: 29856564      PMCID: PMC5980526          DOI: 10.1002/wps.20520

Source DB:  PubMed          Journal:  World Psychiatry        ISSN: 1723-8617            Impact factor:   49.548


× No keyword cloud information.
  11 in total

Review 1.  Long-term antipsychotic use and brain changes in schizophrenia - a systematic review and meta-analysis.

Authors:  Sanna Huhtaniska; Erika Jääskeläinen; Noora Hirvonen; Jukka Remes; Graham K Murray; Juha Veijola; Matti Isohanni; Jouko Miettunen
Journal:  Hum Psychopharmacol       Date:  2017-03       Impact factor: 1.672

Review 2.  A systematic review and meta-analysis of recovery in schizophrenia.

Authors:  Erika Jääskeläinen; Pauliina Juola; Noora Hirvonen; John J McGrath; Sukanta Saha; Matti Isohanni; Juha Veijola; Jouko Miettunen
Journal:  Schizophr Bull       Date:  2012-11-20       Impact factor: 9.306

3.  A multimodal analysis of antipsychotic effects on brain structure and function in first-episode schizophrenia.

Authors:  Tyler A Lesh; Costin Tanase; Benjamin R Geib; Tara A Niendam; Jong H Yoon; Michael J Minzenberg; J Daniel Ragland; Marjorie Solomon; Cameron S Carter
Journal:  JAMA Psychiatry       Date:  2015-03       Impact factor: 21.596

4.  Neuroleptic-induced supersensitivity psychosis: clinical and pharmacologic characteristics.

Authors:  G Chouinard; B D Jones
Journal:  Am J Psychiatry       Date:  1980-01       Impact factor: 18.112

5.  Catamnestic long-term study on the course of life and aging of schizophrenics.

Authors:  L Ciompi
Journal:  Schizophr Bull       Date:  1980       Impact factor: 9.306

Review 6.  Putting the efficacy of psychiatric and general medicine medication into perspective: review of meta-analyses.

Authors:  Stefan Leucht; Sandra Hierl; Werner Kissling; Markus Dold; John M Davis
Journal:  Br J Psychiatry       Date:  2012-02       Impact factor: 9.319

7.  Recovery in remitted first-episode psychosis at 7 years of follow-up of an early dose reduction/discontinuation or maintenance treatment strategy: long-term follow-up of a 2-year randomized clinical trial.

Authors:  Lex Wunderink; Roeline M Nieboer; Durk Wiersma; Sjoerd Sytema; Fokko J Nienhuis
Journal:  JAMA Psychiatry       Date:  2013-09       Impact factor: 21.596

Review 8.  Antipsychotic medication and long-term mortality risk in patients with schizophrenia; a systematic review and meta-analysis.

Authors:  J Vermeulen; G van Rooijen; P Doedens; E Numminen; M van Tricht; L de Haan
Journal:  Psychol Med       Date:  2017-04-11       Impact factor: 7.723

Review 9.  Risk of symptom recurrence with medication discontinuation in first-episode psychosis: a systematic review.

Authors:  Robert B Zipursky; Natasja M Menezes; David L Streiner
Journal:  Schizophr Res       Date:  2013-08-21       Impact factor: 4.939

10.  Reappraising the long-term course and outcome of psychotic disorders: the AESOP-10 study.

Authors:  C Morgan; J Lappin; M Heslin; K Donoghue; B Lomas; U Reininghaus; A Onyejiaka; T Croudace; P B Jones; R M Murray; P Fearon; G A Doody; P Dazzan
Journal:  Psychol Med       Date:  2014-02-26       Impact factor: 7.723

View more
  6 in total

Review 1.  Achieving the Lowest Effective Antipsychotic Dose for Patients with Remitted Psychosis: A Proposed Guided Dose-Reduction Algorithm.

Authors:  Chen-Chung Liu; Hiroyoshi Takeuchi
Journal:  CNS Drugs       Date:  2020-02       Impact factor: 5.749

2.  Sixth Kraepelin Symposium-Understanding and Treating Cognitive Impairment and Depression in Schizophrenia and Affective Disorders.

Authors:  Schaub Annette; Falkai Peter
Journal:  Schizophr Bull       Date:  2019-04-25       Impact factor: 9.306

3.  Eighth Kraepelin Symposium-Translation in Psychiatry and Psychotherapy: A Life-Long Necessity.

Authors:  Schaub Annette; Falkai Peter
Journal:  Schizophr Bull       Date:  2021-04-29       Impact factor: 9.306

4.  Psychiatric hospitalization following antipsychotic medication cessation in first episode psychosis.

Authors:  Joseph F Hayes; David Pj Osborn; Andreas Lundin; Christina Dalman
Journal:  J Psychopharmacol       Date:  2019-02-19       Impact factor: 4.562

5.  The debate regarding maintenance treatment with antipsychotic drugs in schizophrenia.

Authors:  Michael Davidson
Journal:  Dialogues Clin Neurosci       Date:  2018-09       Impact factor: 5.986

Review 6.  Guidelines for Discontinuation of Antipsychotics in Patients Who Recover From First-Episode Schizophrenia Spectrum Disorders: Derived From the Aggregated Opinions of Asian Network of Early Psychosis Experts and Literature Review.

Authors: 
Journal:  Int J Neuropsychopharmacol       Date:  2022-09-28       Impact factor: 5.678

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.